| Important news about salt consumption from Prof. Messerli | Çetin EROL | 1–1 |
| Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort | Harun KUNDİ | 1–120 |
| How much salt is too much salt? | Franz H. MESSERLI,Alexandra NEAGOE,Belinda Nazan WALPOTH | 2–4 |
| Is trans-radial approach related to an increased risk of radiation exposure in patients who underwent diagnostic coronary angiography or percutaneous coronary intervention? (The SAKARYA study) | Çağın Mustafa ÜREYEN,Kahraman COŞANSU,Mustafa Gökhan VURAL,Sait Emir ŞAHİN,İbrahim KOCAYİĞİT,Mustafa Türker PABUCCU,Muhammed Necati Murat AKSOY,Mustafa Tarık AĞAÇ,Ersan TATLI,Hüseyin GÜNDÜZ,Ramazan AKDEMİR | 5–12 |
| Accuracy of three-dimensional systolic dyssynchrony and sphericity indexes for identifying early left ventricular remodeling after acute myocardial infarction | Arnas KARUZAS,Egle RUMBINAITE,Dovydas VERIKAS,Tomas PTASINSKAS,Gintare MUCKIENE,Egle KAZAKAUSKAITE,Vytautas ZABIELA,Renaldas JURKEVICIUS,Jolanta Justina VASKELYTE,Remigijus ZALIUNAS,Diana ZALIADUONYTE PEKSIENE | 13–20 |
| Ross operation early and mid-term results in children and young adults | Oktay KORUN,Arif SELÇUK,Okan YURDAKÖK,Hüsnü Fırat ALTIN,Murat ÇİÇEK,Yiğit KILIÇ,Şefika Türkan KUDSİOĞLU,Mustafa Orhan BULUT,Numan Ali AYDEMİR,Ahmet ŞAŞMAZEL | 21–25 |
| Timing and magnitude of regional right ventricular function and their relationship with early hospital mortality in patients with acute pulmonary embolism | Batur Gönenç KANAR,Anıl ŞAHİN,Gökhan GÖL,Erhan OĞUR,Murat KAVAS,Halil ATAŞ,Bülent MUTLU | 26–32 |
| Anthropometric indices predicting incident hypertension in an Iranian population: The Isfahan cohort study | Masoumeh SADEGHI,Mohammad TALAEI,Mojgan GHARIPOUR,Shahram OVEISGHARAN,Pouya NEZAFATİ,Minoo DIANATKHAH,Nizal SARRAFZADEGAN | 33–43 |
| Papaverine use for radial artery sheath entrapment | Alessandro SCIAHBASI,Andrea CUONO,Alberto MARRANGONI,Stefano RIGATTIERI | 44–45 |
| Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor |